Avricore Health Stock Current Valuation
| AVCR Stock | CAD 0.04 0.01 10.00% |
Valuation analysis of Avricore Health helps investors to measure Avricore Health's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to climb to about 15.8 M in 2025, despite the fact that Enterprise Value Over EBITDA is likely to grow to (66.27). Fundamental drivers impacting Avricore Health's valuation include:
Overvalued
Today
Please note that Avricore Health's price fluctuation is out of control at this time. Calculation of the real value of Avricore Health is based on 3 months time horizon. Increasing Avricore Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Avricore stock is determined by what a typical buyer is willing to pay for full or partial control of Avricore Health. Since Avricore Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Avricore Stock. However, Avricore Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.045 | Real 0.0432 | Hype 0.05 | Naive 0.0498 |
The intrinsic value of Avricore Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Avricore Health's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Avricore Health helps investors to forecast how Avricore stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Avricore Health more accurately as focusing exclusively on Avricore Health's fundamentals will not take into account other important factors: Avricore Health Company Current Valuation Analysis
Avricore Health's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Avricore Health Current Valuation | 4.31 M |
Most of Avricore Health's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avricore Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Avricore Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Avricore Health is extremely important. It helps to project a fair market value of Avricore Stock properly, considering its historical fundamentals such as Current Valuation. Since Avricore Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avricore Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avricore Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Avricore Health has a Current Valuation of 4.31 M. This is 99.97% lower than that of the Biotechnology sector and 99.94% lower than that of the Health Care industry. The current valuation for all Canada stocks is 99.97% higher than that of the company.
Avricore Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avricore Health's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avricore Health could also be used in its relative valuation, which is a method of valuing Avricore Health by comparing valuation metrics of similar companies.Avricore Health is currently under evaluation in current valuation category among its peers.
Avricore Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Avricore Health from analyzing Avricore Health's financial statements. These drivers represent accounts that assess Avricore Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Avricore Health's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 5.7M | 14.8M | 30.8M | 16.9M | 15.2M | 16.0M | |
| Enterprise Value | 6.4M | 12.8M | 30.2M | 16.7M | 15.0M | 15.8M |
Avricore Fundamentals
| Return On Equity | 0.048 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | (0.13) % | ||||
| Current Valuation | 4.31 M | ||||
| Shares Outstanding | 101.29 M | ||||
| Shares Owned By Insiders | 10.19 % | ||||
| Number Of Shares Shorted | 12.14 K | ||||
| Price To Book | 1.83 X | ||||
| Price To Sales | 0.97 X | ||||
| Revenue | 3.49 M | ||||
| Gross Profit | 1.79 M | ||||
| EBITDA | 623.39 K | ||||
| Net Income | (701.22 K) | ||||
| Cash And Equivalents | 122.09 K | ||||
| Total Debt | 40 K | ||||
| Current Ratio | 1.80 X | ||||
| Book Value Per Share | 0.03 X | ||||
| Cash Flow From Operations | 660.4 K | ||||
| Short Ratio | 0.16 X | ||||
| Beta | -2.05 | ||||
| Market Capitalization | 4.56 M | ||||
| Total Asset | 2.54 M | ||||
| Retained Earnings | (31.74 M) | ||||
| Working Capital | 244.34 K | ||||
| Net Asset | 2.54 M |
About Avricore Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Avricore Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avricore Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avricore Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Avricore Stock Analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.